The pharma industry has long recognised the need to move from product- based selling to more customer-centric and value-based engagements, but the COVID-19 pandemic has crystalised the urgency to deliver this change.
Shifting trends in healthcare are adding to the diversity of customer needs, demanding a new and improved approach – a transformation of marketing and cross-functional customer engagement that is truly led by customer needs and focused on their experience (customer-led transformation).
Read the full report here
This is part of a series of posts by LUCENT biopharma – focused on the future of medicines and their marketing in the biopharma sector.
For more information, please go to www.lucentbiopharma.com